Neurocrine Bioscience buy Stifel Nicolaus
Start price
31.07.25
/
50%
€115.25
Target price
31.07.26
€152.22
Performance (%)
30.20%
Price
15.07.26
€150.05
Summary
This prediction is currently active. With a performance of 30.20% the BUY prediction by Stifel_Nicolaus is a big success. This prediction currently runs until 31.07.26. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.752% | -3.752% |
| iShares Core DAX® | -0.097% | 0.537% |
| iShares Nasdaq 100 | 0.585% | -2.390% |
| iShares Nikkei 225® | -0.055% | -2.746% |
| iShares S&P 500 | 0.939% | 1.287% |
Comments by Stifel_Nicolaus for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Stifel Nicolaus from $166.00 to $174.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.35
11.12.25
11.12.25
€160.83
11.12.26
11.12.26
14.24%
15.07.26
15.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€157.11
29.10.26
29.10.26
27.32%
15.07.26
15.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€109.85
18.12.23
18.12.23
€131.90
18.12.24
18.12.24
16.61%
19.12.24
19.12.24